...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith trial partners
5
Jan 29, 2023 02:49PM
1
Jan 30, 2023 10:16AM

Jan 30, 2023 11:58AM
2
Jan 30, 2023 03:07PM
3
Jan 30, 2023 03:27PM
3
Jan 30, 2023 06:05PM
2
Jan 30, 2023 07:22PM

Resverlogix and Zenith have several directors in common and thus by definition, are considered related parties. Like it or not, Donald J. McCaffrey happens to be the Chairman of the Board for both Corporations. As I understand it, the Chairman can choose to do what he sees fit with or without the approval of the shareholders for the benefit of either corporation.  

We mustn't forget that Resverlogix has been supporting Zenith since its inception financially and otherwise. Zenith without the lifelong support from Resverlogix would not have been able to survive on its own all these years.

I see nothing wrong with one company coming to the aid of the other, especially when that support in this instance has been one-sided for a long time. And the fact that most of Zenith's shareholders are also shareholders of Resverlogix. 

The perceived conflict of interest, in this case, runs in both directions. 

 

"All for one and one for all" ... Koo :)

 

2
Jan 31, 2023 10:27AM
1
Feb 01, 2023 01:13PM
5
Feb 01, 2023 06:42PM
2
Feb 01, 2023 08:07PM
3
Feb 01, 2023 09:11PM
2
Feb 01, 2023 11:14PM
5
Feb 02, 2023 02:15AM
5
Feb 02, 2023 12:24PM
2
Feb 02, 2023 12:31PM
2
Feb 02, 2023 02:00PM
3
Feb 02, 2023 03:16PM
2
Feb 02, 2023 03:59PM
2
Feb 02, 2023 04:24PM
1
Feb 02, 2023 06:54PM
2
Feb 04, 2023 06:40PM
Share
New Message
Please login to post a reply